JP Patent

JP5837877B2 — 静脈内投与イブプロフェンを用いた患者の治療

Assigned to カンバーランド ファーマシューティカルズ，インコーポレーテッド · Expires 2015-12-24 · 10y expired

What this patent protects

Patent listed against landiolol-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP5837877B2
Jurisdiction
JP
Classification
—
Expires
2015-12-24
Drug substance claim
No
Drug product claim
No
Assignee
カンバーランド ファーマシューティカルズ，インコーポレーテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.